Miscellaneous Quiz / Rheumatology Meds

Random Miscellaneous Quiz

Can you name the Rheumatology Meds?

 Plays Quiz not verified by Sporcle

Forced Order
Challenge
Share
Tweet
Embed
Score 0/76 Timer 20:00
HintAnswer
Use: Tx postmenopausal osteoporosis. Long term use discouraged d/t SE on breast, uterus, & CVS
NET RESULT = REDUCED SERUM CALCIUM
Pamidronate class
MOA: Secreted by the parafollicular cells of the thyroid; stimu by hyper-Ca.
Alternative to estrogen tx. Prevents the increased risk of breast/uterus CA. Protects spine fxs (not hip).
Reduces serum Ca and phos, reduces osteoclastic bone resorption, decreases renal resorption of Ca & phos. Increases bone mass & reduces spine fx.
MOA: ____ bisphosphonate (___-BPs = more potent) (except etidronate & tiludronate)
SE: Hypercalcemia
Use: Hypercalciuria, prevent stone formation in idiopathic hypercalciuria (by decreasing oxalate excretion & increasing urine Mg and Zn)
SE: The least potent drug & has less side effects
P-kinetics: Poor GI absorption. 50% of the absorbed drug is taken up by bones. Eliminated in urine (unaltered). Absorbed drugs accumulate in bone for months.
Vitamin D2 name
MOA: Produced by adrenal gland. Antagonizes Vit D's effect on intestinal Ca absorption.
MOA: Stimulate renal Ca excretion. Blocks bone formation. Increases osteoclast differentiation.
Calcitonin class
MOA: Accumulated by bone & teeth. Stabilizes the hydroxyapatite crystal. Prevents dental caries & vertebral compression fx.
Use: Prevent dental caries. Not yet approved for osteoporosis
Use: Tx hyperparathyroidism 2nd to chronic renal dz as well as parathyroid CA. In trials for primary hyperparathyroidism
Use: Hypocalcemia & ancillary tx for osteoporosis
MOA: Increases PTH effect on renal Ca resorption & reduced Ca excretion by blocking Na resorption in the proximal tubules.
Alendronate class
1-alpha hydroxyvitamin D2 name
25-Hydroxyvitamin D3 name
Cinacalcet class
Use: Topical tx for psoriasis
Route for Ca gluconate
HintAnswer
SE: GI symptoms, nausea, flush
Use: Tx secondary hyperparathyroidism in renal failure pts
PTH Use
PTH (or its analog recombinate Teriparatide 1-34) class
Class MOA: Binds to receptors thru-out body. Regulates Ca & phos serum levels; promotes absorption in the GI; promote renal reabsorption of Ca.
Estrogens class
Class MOA: Promotes bone formation. Inihibits PTH secretion. Promotes immunosuppression, phagocytosis, & anti-tumor activity
Glucocorticoids class
19-nor-1,25-Dihydroxyvitamin D2
MOA: Activated form made from calcidiol in the kidneys & tissues; the most potent steroid hormone in the body
MOA: Enhance absorption of Ca from the GI (stim production of active Vit. D in the kidney). Supress of Ca loss in urine (stim reabsorption of Ca). Stim loss of phos in urine.
Class MOA: Stimulates new bone formation
Rx interactions: lipophilic-intestinal absorption reduced by statins & cholestyramine (take the drugs a few hrs apart). CS blocks GI vit D absorption.
SE: Major SE: gastritis, esophagitis (caused by GERD) -- to minimize: take w/ H2O and remain upright for 30 min.
Zolendronate class
Etidronate class
SE: Overdose -> dental fluorosis (yellow teeth)
MOA: NET RESULT = REDUCED RENAL EXCRETION OF CA
MOA: Analogues of pyrophosphate (PPI - inhibits calcification in plasma but easily degraded by alk phos) -- P-C-P core is less degradable.
Use: Hypercalcemia of malignancy
MOA: Act on Ca sensing receptor (CaR) and LOWER its sensitivity --> block of PTH secretion.
MOA: A sex hormone. Reduces PTH's effect on bone resorption (via OPG). NET RESULT = BLOCKS BONE LOSS
Use: Tx hypercalcemia assoc w/ malignancy, Paget's dz, & postemenopausal osteoporosis
Vitamin D3 name
Use: serum Vit D concentration testing
SE: Long term -->: osteoporosis
HintAnswer
Use: tx of hypoparathyroidism, refractory rickets, & familal hypophosphatemia
Use: Tx hypercalcemia, Paget's disease, osteoporosis
MOA: NET RESULT = INCREASED SERUM CA AND DECREASED SERUM PHOSPHATE.
Drug MOA: Made in the lab by radiating fungus; not naturally occuring in the body
MOA: RESULT = REDUCED PTH RELEASE FROM PARATHYROID GLAND
MOA: Regulates Ca & Phos conc in ECF. Mobilizes Ca from bone (stim osteoclast diff via RANKL).
SE: Has the most significant effects. Risk of femoral fx (atypical subtrochanteric & diaphyseal breaks)
MOA: Reduces bone resorption
Drugs that induce osteoporosis
Riserdronate class
Drug MOA: Naturally occuring form made by the skin upon sun exposure; found in food & most supplements
MOA: Binds to hydroxyapatite & retards formation & dissolution of hydroxyapatite crystals (slow down resorption) --> decreased resorption by osteoclasts & modest increase in BMD.
1,25-Dihydroxyvitamin D3 name
Use: Tx hyper-Ca assoc w/ malignancy & granulomatous dz. Useful in Vit. D intoxication
MOA: Blocks farnesyl pyrophosphate synthase in the HMG-CoA reductase pathway (mevolante pathway) --> osteoclast apoptosis. Increase bone density; reduce fx in hips, spines, etc.
Use: Tx hypophosphatemia & hypercalcemia
Tiludronate class
Rx interactions: P450 inducers (phenytoin & phenobarbital) increase liver metabolism to inactivate product.
24,25 Dihydroxyvitamin D3 name
Calciprotriene name (analog)
Use: Tx hypocalcemia & helps to tx hyperphosphatemia.
SE: Long term use is assoc w/ breast cancer.
Ibandronate class
MOA: Prehormone made directly from cholecalciferol in the liver; low biologic activity, major form circulating in the blood

You're not logged in!

Compare scores with friends on all Sporcle quizzes.
Join for Free
OR
Log In

You Might Also Like...

Show Comments

Extras

Created Dec 13, 2011ReportFavoriteNominate
Tags:med

Top Quizzes Today


Score Distribution

Your Account Isn't Verified!

In order to create a playlist on Sporcle, you need to verify the email address you used during registration. Go to your Sporcle Settings to finish the process.

Report this User

Report this user for behavior that violates our Community Guidelines.

Details: